Catherine Moukheibir

Catherine Moukheibir currently serves on the Board of Directors at DNA Script, Asceneuron, Biotalys, CMR Surgical, Ironwood Pharmaceuticals and Orphazyme. She has previously held board memberships at Kymab, GenKyoTex, Cerenis, Zealand, Ablynx and Creabilis. Ms. Moukheibir was Chair and CEO of MedDay Pharmaceuticals and has also held senior executive positions at Innate Pharma, Movetis, and Zeltia Group. Before moving into the life sciences industry, Ms. Moukheibir worked in investment banking. She received an MBA and a Masters in Economics from Yale University.